chr7-117426924-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -11 ACMG points: 0P and 11B. BP4_StrongBP6_ModerateBP7BS2
The NM_130768.3(ASZ1):c.117G>A(p.Arg39Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00851 in 1,593,834 control chromosomes in the GnomAD database, including 79 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.0059 ( 6 hom., cov: 32)
Exomes 𝑓: 0.0088 ( 73 hom. )
Consequence
ASZ1
NM_130768.3 synonymous
NM_130768.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.52
Genes affected
ASZ1 (HGNC:1350): (ankyrin repeat, SAM and basic leucine zipper domain containing 1) Predicted to be involved in gamete generation and piRNA metabolic process. Predicted to be located in cytoplasm. Predicted to be active in pi-body. [provided by Alliance of Genome Resources, Apr 2022]
CFTR (HGNC:1884): (CF transmembrane conductance regulator) This gene encodes a member of the ATP-binding cassette (ABC) transporter superfamily. The encoded protein functions as a chloride channel, making it unique among members of this protein family, and controls ion and water secretion and absorption in epithelial tissues. Channel activation is mediated by cycles of regulatory domain phosphorylation, ATP-binding by the nucleotide-binding domains, and ATP hydrolysis. Mutations in this gene cause cystic fibrosis, the most common lethal genetic disorder in populations of Northern European descent. The most frequently occurring mutation in cystic fibrosis, DeltaF508, results in impaired folding and trafficking of the encoded protein. Multiple pseudogenes have been identified in the human genome. [provided by RefSeq, Aug 2017]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -11 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 7-117426924-C-T is Benign according to our data. Variant chr7-117426924-C-T is described in ClinVar as [Benign]. Clinvar id is 787673.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=-2.53 with no splicing effect.
BS2
High Homozygotes in GnomAd4 at 6 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ASZ1 | NM_130768.3 | c.117G>A | p.Arg39Arg | synonymous_variant | Exon 2 of 13 | ENST00000284629.7 | NP_570124.1 | |
ASZ1 | NM_001301821.2 | c.117G>A | p.Arg39Arg | synonymous_variant | Exon 2 of 13 | NP_001288750.1 | ||
ASZ1 | NM_001301822.2 | c.-396G>A | 5_prime_UTR_variant | Exon 2 of 12 | NP_001288751.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00591 AC: 898AN: 151988Hom.: 6 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
898
AN:
151988
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00715 AC: 1671AN: 233814 AF XY: 0.00755 show subpopulations
GnomAD2 exomes
AF:
AC:
1671
AN:
233814
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00878 AC: 12661AN: 1441728Hom.: 73 Cov.: 30 AF XY: 0.00877 AC XY: 6281AN XY: 716368 show subpopulations
GnomAD4 exome
AF:
AC:
12661
AN:
1441728
Hom.:
Cov.:
30
AF XY:
AC XY:
6281
AN XY:
716368
Gnomad4 AFR exome
AF:
AC:
48
AN:
31942
Gnomad4 AMR exome
AF:
AC:
130
AN:
39634
Gnomad4 ASJ exome
AF:
AC:
63
AN:
25336
Gnomad4 EAS exome
AF:
AC:
0
AN:
39532
Gnomad4 SAS exome
AF:
AC:
436
AN:
80314
Gnomad4 FIN exome
AF:
AC:
216
AN:
53052
Gnomad4 NFE exome
AF:
AC:
11287
AN:
1106732
Gnomad4 Remaining exome
AF:
AC:
460
AN:
59528
Heterozygous variant carriers
0
601
1202
1802
2403
3004
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
398
796
1194
1592
1990
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00590 AC: 897AN: 152106Hom.: 6 Cov.: 32 AF XY: 0.00531 AC XY: 395AN XY: 74362 show subpopulations
GnomAD4 genome
AF:
AC:
897
AN:
152106
Hom.:
Cov.:
32
AF XY:
AC XY:
395
AN XY:
74362
Gnomad4 AFR
AF:
AC:
0.00142182
AN:
0.00142182
Gnomad4 AMR
AF:
AC:
0.00464477
AN:
0.00464477
Gnomad4 ASJ
AF:
AC:
0.00230548
AN:
0.00230548
Gnomad4 EAS
AF:
AC:
0
AN:
0
Gnomad4 SAS
AF:
AC:
0.0052105
AN:
0.0052105
Gnomad4 FIN
AF:
AC:
0.00369108
AN:
0.00369108
Gnomad4 NFE
AF:
AC:
0.0101327
AN:
0.0101327
Gnomad4 OTH
AF:
AC:
0.002849
AN:
0.002849
Heterozygous variant carriers
0
43
86
128
171
214
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
6
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Jul 15, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at